脂蛋白相关磷脂酶A2及其与冠心病相关性的研究进展

被引：2

作者：

马明坤 ^{[1
]}

贾克刚 ^{[2
]}

机构：

[1] 天津中医药大学第二附属医院检验科

[2] 泰达国际心血管病医院检验科

来源：

检验医学 | 2010年 / 25卷 / 09期

关键词：

脂蛋白相关磷脂酶A2; 冠心病; 相关性;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：740 / 743

页数：4

共 9 条

[1] 血清脂蛋白相关磷脂酶A2与冠状动脉粥样硬化斑块稳定性的相关研究——附107例报告 [J].

刘军妮 ;

徐冬玲 ;

杜贻萌 ;

姚桂华 ;

蒋卫东 ;

赵敬杰 ;

董兆强 ;

隋树建 ;

王欣 ;

鹿庆华 .

新医学, 2009, 40 (01) :18-20+46

[2] 脂蛋白相关磷脂酶A2与动脉粥样硬化的关系 [J].

刘建辉 ;

张春妮 .

中国动脉硬化杂志, 2008, (07) :569-571

[3] 磷脂酶A2及其功能概述 [J].

张鹭 ;

张浩 .

齐齐哈尔医学院学报, 2004, (02) :178-180

[4] Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target [J].

Packard, Chris J. .

CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) :358-363

[5] Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target [J].

Ali, Muzammil ;

Madjid, Mohammad .

FUTURE CARDIOLOGY, 2009, 5 (02) :159-173

[6] Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: Lipoprotein associated phospholipase A2, and myeloperoxidase [J].

Moldoveanu, Elena ;

Mut-Vitcu, Bogdan ;

Tanaseanu, George R. ;

Marta, Daciana S. ;

Manea, Gabriela ;

Kosaka, Tetsuya ;

Vidulescu, Cristina ;

Tanaseanu, Cristina .

CLINICAL BIOCHEMISTRY, 2008, 41 (18) :1429-1433

[7] Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft Vasculopathy and increased risk of cardiovascular events in heart transplant patients [J].

Raichlin, Eugenia ;

McConnell, Joseph P. ;

Bae, Jang-Ho ;

Kremers, Walter K. ;

Lerman, Amir ;

Frantz, Robert P. .

TRANSPLANTATION, 2008, 85 (07) :963-968

[8]

Lipoprotein-associated phospholipase A<Subscript>2</Subscript> for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach.[J].M. Möckel;Reinhold Müller;Jörn O. Vollert;Christian Müller;Oilver Danne;Ragnar Gareis;Thomas Störk;Rainer Dietz;Wolfgang Koenig.Clinical Research in Cardiology.2007, 9

[9]

Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial.[J].Michelle O’Donoghue;David A. Morrow;Marc S. Sabatine;Sabina A. Murphy;Carolyn H. McCabe;Christopher P. Cannon;Eugene Braunwald.Circulation.2006, 14

← 1 →